Voltaren Emulgel from GSK PLC - cooling relief for sore knees and backs

Reviewed: ad hoc news Lifestyle & Consumer desk. Edited and checked on 2026-06-26, 13:05. Details in the imprint.

Voltaren Emulgel lands on the skin as a cool, transparent strip, spreads smoothly under the fingers and leaves a faint medicinal scent while the first chill hits the sore joint. For millions, that small blue-and-white tube is the evening ritual after work or sport.

How Voltaren Emulgel works

Voltaren Emulgel is a topical anti-inflammatory gel that delivers the non-steroidal drug diclofenac directly to the affected muscle or joint where pain and swelling occur.The official GSK product overview explains the Voltaren range and diclofenac use. Unlike oral painkillers, the gel is applied on the skin surface, aiming for local action with lower systemic exposure.

The emulsion-gel base is designed to penetrate the skin barrier and carry diclofenac into underlying tissues, which can be helpful for conditions like osteoarthritis of the knee, tendonitis or minor sports injuries. Many users like that they can see and control exactly where the medicine goes.

What patients will notice

On application, Voltaren Emulgel feels cool and slightly tacky before drying to a thin, non-greasy film that does not stain clothes. The scent is clearly pharmaceutical but fades within minutes for most people. The gel can be used up to three or four times per day, depending on local labeling.

Clinical studies cited by GSK show that diclofenac gel can provide meaningful pain relief and improved mobility in osteoarthritis of superficial joints like knees and hands compared with placebo.Haleon summarises the clinical data for Voltaren gel in healthcare-professional materials For chronic users, the ability to keep systemic NSAID doses lower is a practical benefit.

Position in the pain market

Chief executive Emma Walmsley routinely highlights GSK's consumer legacy and the spin-off Haleon portfolio when asked about the group's broader pain and self-care footprint in investor calls.GSK's recent results presentations emphasise both biopharma and former consumer brands such as Voltaren While Haleon now steers day-to-day branding in many markets, Voltaren still sits in investor minds as a GSK-era cornerstone.

Across Europe, Voltaren Emulgel is available over the counter in pharmacies and drugstores, often in 50 g, 100 g and 150 g tubes. In Germany, the gel is one of the more visible topical NSAIDs on the shelf, typically positioned near ibuprofen and diclofenac tablets at eye level.

Strengths and limitations

One clear strength is flexibility of use. Office workers rub it into a stiff neck after long laptop sessions, while runners reach for it after a hard 10 km training run. The tactile routine of massage itself becomes part of the relief for many users.

However, Voltaren Emulgel is not a cure and does not suit everyone. People with known NSAID allergies, a history of certain gastrointestinal problems, or taking specific medications need medical advice before using diclofenac, even topically. And for deep-seated back pain, oral or systemic therapies may still be required.

Company context and GSK shares

GSK PLC focuses today on prescription vaccines and specialty medicines, but legacy consumer names like Voltaren still matter for brand recognition with patients and investors. On the London Stock Exchange, GSK PLC shares (ISIN GB0009252882) trade in pounds sterling as one of the larger healthcare names in the FTSE 100.

This article was AI-assisted and editorially reviewed. Product information without guarantee; prices and availability may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions involve risks up to total loss.